Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common form of dementia, affecting millions of people worldwide. Unfortunately, none of the current treatments are effective at improving cognitive function in AD patients and, therefore, there is an urgent need for the development of new therapies that target th...
Main Authors: | Maria Calvo-Rodriguez, Elizabeth K. Kharitonova, Brian J. Bacskai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/11/2513 |
Similar Items
-
High mitochondrial calcium levels precede neuronal death in vivo in Alzheimer’s disease
by: Maria Calvo-Rodriguez, et al.
Published: (2020-06-01) -
Calcium Signaling Regulated by Cellular Membrane Systems and Calcium Homeostasis Perturbed in Alzheimer’s Disease
by: Dong-Xu Huang, et al.
Published: (2022-02-01) -
The contribution of mitochondria-associated endoplasmic reticulum membranes (MAMs) dysfunction in Alzheimer’s disease and the potential countermeasure
by: Zehui Li, et al.
Published: (2023-03-01) -
Proposed mechanisms of tau: relationships to traumatic brain injury, Alzheimer’s disease, and epilepsy
by: Samantha P. Martin, et al.
Published: (2024-01-01) -
Presenilin mutations deregulate mitochondrial Ca2+ homeostasis and metabolic activity causing neurodegeneration in Caenorhabditis elegans
by: Shaarika Sarasija, et al.
Published: (2018-07-01)